carole mitnick
carole mitnick
Associate Professor, Harvard Medical School
Verified email at
Cited by
Cited by
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ...
European Respiratory Journal 38 (3), 516-528, 2011
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru
C Mitnick, J Bayona, E Palacios, S Shin, J Furin, F Alcántara, E Sánchez, ...
New England Journal of Medicine 348 (2), 119-128, 2003
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ...
Public Library of Science 9 (8), e1001300, 2012
Comprehensive treatment of extensively drug-resistant tuberculosis
CD Mitnick, SS Shin, KJ Seung, ML Rich, SS Atwood, JJ Furin, ...
New England Journal of Medicine 359 (6), 563-574, 2008
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis
KF Laserson, LE Thorpe, V Leimane, K Weyer, CD Mitnick, V Riekstina, ...
The International Journal of Tuberculosis and Lung Disease 9 (6), 640-645, 2005
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
TCG for the Meta, N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, ...
The Lancet 392 (10150), 821-834, 2018
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis
KR Jacobson, DB Tierney, CY Jeon, CD Mitnick, MB Murray
Clinical infectious diseases 51 (1), 6-14, 2010
The dilemma of MDR-TB in the global era [Counterpoint]
P Farmer, J Bayona, M Becerra, J Furin, C Henry, H Hiatt, JY Kim, ...
The International Journal of Tuberculosis and Lung Disease 2 (11), 869-876, 1998
Tuberculosis and chronic respiratory disease: a systematic review
AL Byrne, BJ Marais, CD Mitnick, L Lecca, GB Marks
International Journal of Infectious Diseases 32, 138-146, 2015
Multidrug-resistant tuberculosis management in resource-limited settings
E Nathanson, C Lambregts-van Weezenbeek, ML Rich, R Gupta, ...
Emerging infectious diseases 12 (9), 1389, 2006
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
P Nahid, SR Mase, GB Migliori, G Sotgiu, GH Bothamley, JL Brozek, ...
American journal of respiratory and critical care medicine 200 (10), e93-e142, 2019
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis
J Furin J, D Mitnick C, S Shin S, J Bayona, C Becerra M, M Singler J, ...
The International Journal of Tuberculosis and Lung Disease 5 (7), 648-655, 2001
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment
MF Franke, SC Appleton, J Bayona, F Arteaga, E Palacios, K Llaro, ...
Clinical infectious diseases 46 (12), 1844-1851, 2008
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study
MC Becerra, SC Appleton, MF Franke, K Chalco, F Arteaga, J Bayona, ...
The Lancet 377 (9760), 147-152, 2011
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
EV Kurbatova, A Taylor, VM Gammino, J Bayona, M Becerra, M Danilovitz, ...
Tuberculosis 92 (5), 397-403, 2012
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two …
EV Kurbatova, JP Cegielski, C Lienhardt, R Akksilp, J Bayona, ...
The Lancet Respiratory medicine 3 (3), 201-209, 2015
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea
SK Park, WC Lee, DH Lee, CD Mitnick, L Han, KJ Seung
The International Journal of Tuberculosis and Lung Disease 8 (3), 361-368, 2004
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?
KE Dooley, EA Obuku, N Durakovic, V Belitsky, C Mitnick, ...
The Journal of infectious diseases 207 (9), 1352-1358, 2013
Tuberculosis pharmacotherapy: strategies to optimize patient care
CD Mitnick, B McGee, CA Peloquin
Expert opinion on pharmacotherapy 10 (3), 381-401, 2009
Community-based therapy for children with multidrug-resistant tuberculosis
PC Drobac, JS Mukherjee, JK Joseph, C Mitnick, JJ Furin, H del Castillo, ...
Pediatrics 117 (6), 2022-2029, 2006
The system can't perform the operation now. Try again later.
Articles 1–20